Hyderabad: A day after announcing his decision to quit active politics, Vijayasai Reddy has submitted his resignation as a Rajya Sabha member. On Saturday, he met with Rajya Sabha Chairman Jagdeep ...
Vijaya Sai Reddy resigned from the YSR Congress Party (YSRCP) as he had ‘lost his trust’ in the party president Y. S. Jagan Mohan Reddy. Addressing the media after participating in a ‘Thali ...
Yuvajana Sramika Rythu Congress Party (YSRCP) General Secretary V Vijayasai Reddy announced on Friday, January 24, that he would resign as the Rajya Sabha MP and also quit politics on January 25.
Hyderabad: Telangana Chief Minister Revanth Reddy has returned to Hyderabad after completing his successful tour of Davos. He arrived at Rajiv Gandhi International Airport (RGIA) via Dubai ...
PSAI Business Revenue: USD97 million, 3% YoY growth, 3% QoQ decline. Dr Reddy's Laboratories Ltd (NYSE:RDY) reported a double-digit top line growth of 16% year-on-year, driven by strong ...
Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...
(Image: Freepik) Dr Reddy’s Lab share prices fell 5.5% to a low of Rs 1,218 as soon as the scrip started trading on the National Stock Exchanges on January 24. The dip in the share price of Dr ...
Janardhana Reddy has shocked many. However, for those observing political developments in Ballari, this was waiting to happen for some time. The tension escalated after BJP national general ...
VIJAYAWADA: In a major setback to the YSRCP, party Rajya Sabha MP V Vijayasai Reddy has announced his decision to quit active politics. “I am retiring from politics. I will resign from Rajya ...
HYDERABAD: Dr D Nageshwar Reddy, chairman of AIG Hospitals, was conferred the Padma Vibhushan, the second-highest civilian award, on Saturday for his outstanding contributions to public health ...
New Delhi: The 7th annual e-auctions for DD Freedish concluded on Friday with the final two successful bidders -- India TV and TV9 Bharatvarsh -- winning a slot each for Rs 8.25 crore.
While drugmaker Dr Reddy's Laboratories' Q3 earnings were slightly above the Street's estimates, the highlight of the show was declining revenue contribution from Revlimid, which also weighed on ...